M X13 (Pramipexole dihydrochloride 0.75 mg)

Pill imprint M X13 has been identified as Pramipexole dihydrochloride 0.75 mg.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.75 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pramipexole dihydrochloride

Imprint:

M X13

Strength:

0.75 mg

Color:

Gray

Shape:

Round

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-1713

Inactive Ingredients:

silicon dioxide
crospovidone
hydroxypropyl cellulose (type h)
magnesium stearate
mannitol
corn starch
sodium citrate
FD&C Yellow No. 6
FD&C Blue No. 2

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.